Qiagen closed higher Friday after the diagnostics company reaffirmed the efficacy of its PCR tests against the new Covid variant which scrambled stock markets on Friday.
The stock closed 3.5% higher at $56.47.
Qiagen (ticker: QGEN) said it assessed its SARS-CoV-2 PCR tests against the new genetic mutations of the variant, known by its scientific…
https://www.washingtonpost.com/travel/2022/05/25/cdc-monkeypox-travel-advisory/
Read morehttps://neurosciencenews.com/genetics-cerebrovascular-alzheimers-20669/
Read morehttps://www.cnbc.com/2022/05/26/vaccines-offer-little-protection-against-long-covid-study-finds.html
Read morehttps://www.eurekalert.org/news-releases/953469
Read morehttps://slate.com/technology/2022/05/monkeypox-outbreak-2003-prairie-dogs.html
Read more
